Studies with dual neprilysin-angiotensin receptor II inhibition of sacubitril/valsartan demonstrated positive results but only in heart failure patients with reduced ejection fraction. Valsartan, however, is not the only sartan, and enalapril is not the only or the best among the angiotensin-converting enzyme blockers. More on the video.
- Heart Rate Variability: for real doctors. Regulation in human health. Heart rate and TP of HRV
- Human physiological and pathological orthostatic blood pressure reactions